| Elvia G Moreta Freire, MD | |
|
2854 Highway 55 Ste 190, Eagan, MN 55121-1783 | |
| (651) 644-4277 | |
| (651) 644-4018 |
| Full Name | Elvia G Moreta Freire |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 36 Years |
| Location | 2854 Highway 55 Ste 190, Eagan, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275566929 | NPI | - | NPPES |
| 570715300 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 40077 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Minnesota Medical Center, Fairview | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Paul Rheumatology P A | 0941264741 | 3 |
News Archive
MICARDIS® is the first treatment in its class to be approved for this indication. The EMEA approval is the second major milestone for MICARDIS® in cardiovascular protection. It follows the approval by the US FDA for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take ACE inhibitors.
China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the financial results for the quarter ended September 30, 2015.
A novel telemedicine lung cancer screening effort during the COVID-19 pandemic shows that virtual single-visit screenings are just as effective as single-visit screenings done in person at the hospital, according to a study presented at the American College of Surgeons Virtual Clinical Congress 2021.
Posteroanterior mobilization is effective for reducing spinal stiffness and the magnitude of pain in patients with low back pain, study findings show.
› Verified 1 days ago
| Entity Name | St Paul Rheumatology P A |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053344788 PECOS PAC ID: 0941264741 Enrollment ID: O20041111001060 |
News Archive
MICARDIS® is the first treatment in its class to be approved for this indication. The EMEA approval is the second major milestone for MICARDIS® in cardiovascular protection. It follows the approval by the US FDA for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take ACE inhibitors.
China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the financial results for the quarter ended September 30, 2015.
A novel telemedicine lung cancer screening effort during the COVID-19 pandemic shows that virtual single-visit screenings are just as effective as single-visit screenings done in person at the hospital, according to a study presented at the American College of Surgeons Virtual Clinical Congress 2021.
Posteroanterior mobilization is effective for reducing spinal stiffness and the magnitude of pain in patients with low back pain, study findings show.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elvia G Moreta Freire, MD 2854 Highway 55 Ste 130, Eagan, MN 55121-1776 Ph: (651) 224-4930 | Elvia G Moreta Freire, MD 2854 Highway 55 Ste 190, Eagan, MN 55121-1783 Ph: (651) 644-4277 |
News Archive
MICARDIS® is the first treatment in its class to be approved for this indication. The EMEA approval is the second major milestone for MICARDIS® in cardiovascular protection. It follows the approval by the US FDA for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take ACE inhibitors.
China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the financial results for the quarter ended September 30, 2015.
A novel telemedicine lung cancer screening effort during the COVID-19 pandemic shows that virtual single-visit screenings are just as effective as single-visit screenings done in person at the hospital, according to a study presented at the American College of Surgeons Virtual Clinical Congress 2021.
Posteroanterior mobilization is effective for reducing spinal stiffness and the magnitude of pain in patients with low back pain, study findings show.
› Verified 1 days ago
Dr. Paul Anthony Karazija, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 3400 Yankee Dr, R416, Eagan, MN 55121 Phone: 651-662-2566 | |
Laurie Jepson, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3305 Central Park Village Dr Ste 200, Eagan, MN 55121 Phone: 651-406-8860 Fax: 651-688-7864 | |
Sajan Jiv Singh Nagpal, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1185 Town Centre Dr Ste 205, Eagan, MN 55123 Phone: 612-871-1145 Fax: 612-870-5491 | |
Ashish K Tiwari, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1185 Town Centre Dr Ste 205, Eagan, MN 55123 Phone: 612-871-1145 Fax: 612-870-5491 | |
Sarah Mcintire, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1440 Duckwood Dr, Eagan, MN 55122 Phone: 651-406-8860 | |
Erin Elizabeth Mccarville, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1440 Duckwood Dr, Eagan, MN 55122 Phone: 651-406-8880 | |
Janine Pingel, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1440 Duckwood Dr, Eagan, MN 55122 Phone: 651-406-8880 |